Results 101 to 110 of about 7,513 (190)

Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment

open access: yes, 2003
The object of this study was to investigate whether the levels of cardiolipin in cultured skin fibroblasts of patients with Barth syndrome (BTHS) can be restored by addition of linoleic acid to growth media.
Vaz, F. M.   +5 more
core   +1 more source

Your Heart on a Chip: iPSC-Based Modeling of Barth-Syndrome-Associated Cardiomyopathy

open access: yes, 2014
Disease-specific induced pluripotent stem cells (iPSCs) are invaluable tools for studying genetic disorders in a dish. A recent paper by Wang et al.
Zweigerdt, Robert   +5 more
core   +1 more source

Tafazzin-deficient zebrafish display mitochondrial dysfunction, neutropenia, and metabolic defects without myopathy

open access: yesScientific Reports
Barth syndrome is an X-linked syndrome characterized by cardiomyopathy, skeletal myopathy, and neutropenia. This life-threatening disorder results from loss-of-function mutations in TAFAZZIN, which encodes a phospholipid-lysophospholipid transacylase ...
Usua Oyarbide   +10 more
doaj   +1 more source

Corrigendum: Re-expression of tafazzin isoforms in TAZ-deficient C6 glioma cells restores cardiolipin composition but not proliferation rate and alterations in gene expression

open access: yesFrontiers in Genetics, 2022
Gayatri Jagirdar   +11 more
doaj   +1 more source

The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome

open access: yes, 2004
Barth syndrome is a genetic disorder that is caused by different mutations in the TAZ gene G4.5. The yeast gene TAZ1 is highly homologous to human TAZ, and the taz1Delta mutant has phospholipid defects similar to those observed in Barth syndrome cells ...
Ma, Lining   +4 more
core   +1 more source

The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome

open access: yes, 2017
The PGC-1α/PPAR axis has been proposed as a potential therapeutic target for several metabolic disorders. The aim was to evaluate the efficacy of the pan-PPAR agonist, bezafibrate, in tafazzin knockdown mice (TazKD), a mouse model of Barth syndrome that ...
Glukhov, Alexander V.   +25 more
core   +1 more source

Intra-individual plasticity of the TAZ gene leading to different heritable mutations in siblings with Barth syndrome

open access: yes, 2015
Infantile-onset skeletal myopathy Barth syndrome (OMIM #302060) is caused by mutations in the X-linked TAZ gene and hence usually manifests itself only in hemizygous males. Confirmatory testing is provided by mutational analysis of the TAZ gene and/or by
Serena Gasperini   +28 more
core   +1 more source

Barth syndrome cardiomyopathy

open access: yes, 2018
Barth syndrome (BTHS) is an inherited form of cardiomyopathy, caused by a mutation within the gene encoding the mitochondrial transacylase tafazzin. Tafazzin is involved in the biosynthesis of the unique phospholipid cardiolipin (CL), which is almost exclusively found in mitochondrial membranes.
Dudek, Jan, Maack, Christoph
openaire   +1 more source

Activation of the integrated stress response rewires cardiac metabolism in Barth syndrome. [PDF]

open access: yesBasic Res Cardiol, 2023
Kutschka I   +24 more
europepmc   +1 more source

BARTH SYNDROME – X-LINKED CARDIOMYOPATHY WITH NEUTROPENIA

open access: yes, 2012
Opisujemo dijete s Barthovim sindromom. Uz pozitivnu obiteljsku anamnezu (X-vezana bolest) i osnovne kliničke simptome (teška dilatacijska kardiomiopatija, generalizirana miopatija s hipotonijom) dijete ima i karakteristične laboratorijske nalaze ...
Bartoniček, Dorotea   +4 more
core  

Home - About - Disclaimer - Privacy